Physician profile
Kari L Ring
NPI 1790949600
$13,867.21
in general payments reported to CMS, 2019-2025
7 companies · $1,115 in 2025
The $1,115 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2021: $73.72 · 2022: $145 · 2023: $151 · 2024: $12K · 2025: $1,115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $1,464 · Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,615.00 |
| Travel and Lodging | $1,463.85 |
| Food and Beverage | $447.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $10,240.36 | 2024-2025 | Surgicel Nu-Knit, Stratafix, Harmonic |
| Ethicon Endo-Surgery INC. | $2,525.00 | 2024 | Harmonic, Enseal |
| Ethicon US, LLC | $962.75 | 2019-2025 | Harmonic, Enseal, Stratafix |
| Medtronic, INC. | $55.13 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $48.80 | 2023 | Lynparza |
| Genmab U.S., INC. | $35.17 | 2023 | Tivdak |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Ring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.